How to facilitate early diagnosis of CNS involvement in malignant lymphoma

被引:11
作者
Korfel, Agnieszka [1 ]
Nowosielski, Martha [2 ]
Pardo-Moreno, Javier [3 ]
Javier Penalver, Francisco [4 ]
Buda, Gabriele [5 ]
Bennani, Hind [6 ]
Costopoulos, Myrto [7 ]
Le Garff-Tavernier, Magali [7 ]
Soussain, Carole [8 ]
Schmid, Mathias [9 ]
Alberto Orfao, Jose [10 ,11 ]
Glantz, Michael [12 ]
机构
[1] Charite Univ Med Berlin, Dept Hematol Oncol & Tumor Immunol, Hindenburgdamm 30, D-12200 Berlin, Germany
[2] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria
[3] Univ Hosp King Juan Carlos, Dept Neurol, Madrid, Spain
[4] Univ Hosp Fdn Alcorcon, Dept Hematol, Madrid, Spain
[5] Univ Pisa, Dept Hematol & Oncol, Pisa, Italy
[6] Hop Foch, Dept Biol, Suresnes, France
[7] Hop La Pitie Salpetriere, Dept Biol Hematol, Paris, France
[8] Hop Rene Huguenin, Inst Curie, Dept Hematol, Paris, France
[9] Stadtspital Triemli Zurich, Dept Hematol & Oncol, Zurich, Switzerland
[10] Univ Salamanca, Dept Med, Salamanca, Spain
[11] Univ Salamanca, Cytometry Serv, Salamanca, Spain
[12] Penn State Coll Med, Hershey, PA USA
关键词
Secondary CNS lymphoma; parenchymal; meningeal; cerebrospinal fluid cytomorphology; cerebrospinal fluid flow cytometry; novel markers; response criteria; neuroaxis MRI; NERVOUS-SYSTEM LYMPHOMA; B-CELL LYMPHOMA; CEREBROSPINAL-FLUID CYTOLOGY; NON-HODGKINS-LYMPHOMA; OCCULT LEPTOMENINGEAL DISEASE; INVERSION-RECOVERY IMAGES; CSF SOLUBLE CD27; DIFFERENTIAL-DIAGNOSIS; FLOW-CYTOMETRY; SOLID TUMORS;
D O I
10.1080/17474086.2016.1242405
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Making the diagnosis of secondary CNS involvement in lymphoma can be difficult due to unspecific signs and symptoms, limited accessibility of brain/myelon parenchyma and low sensitivity and/or specifity of imaging and cerebrospinal fluid (CSF) examination currently available.Areas covered: MRI of the total neuroaxis followed by CSF cytomorphology and flow cytometry are methods of choice when CNS lymphoma (CNSL) is suspected. To reduce the numerous pitfalls of these examinations several aspects should be considered. New CSF biomarkers might be of potential diagnostic value. Attempts to standardize response criteria are presented.Expert commentary: Diagnosing CNSL remains challenging. Until diagnostic methods combining high sensitivity with high specifity are routinely introduced, high level of awareness and optimal utilization of examinations currently available are needed to early diagnose this potentially devastating disease.
引用
收藏
页码:1081 / 1091
页数:11
相关论文
共 82 条
[1]   Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma [J].
Abrey, LE ;
Batchelor, TT ;
Ferreri, AJM ;
Gospodarowicz, M ;
Pulczynski, EJ ;
Zucca, E ;
Smith, JR ;
Korfel, A ;
Soussain, C ;
DeAngelis, LM ;
Neuwelt, EA ;
O'Neill, BP ;
Thiel, E ;
Shenkier, T ;
Graus, F ;
van den Bent, M ;
Seymour, JF ;
Poortmans, P ;
Armitage, JO ;
Cavalli, F .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :5034-5043
[2]   Malignant meningitis presenting as pseudotumor cerebri [J].
Ahmed, R. M. ;
Halmagyi, G. M. .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2013, 329 (1-2) :62-65
[3]   The incidence of secondary central nervous system involvement in patients with non-Hodgkin's lymphoma as detected by 18F-FDG PET/CT [J].
Akkas, Burcu E. ;
Vural, Gulin U. .
NUCLEAR MEDICINE COMMUNICATIONS, 2013, 34 (01) :50-56
[4]   Clinical relevance of flow cytometric immunophenotyping of the cerebrospinal fluid in patients with diffuse large B-cell lymphoma [J].
Alvarez, R. ;
Dupuis, J. ;
Plonquet, A. ;
Christov, C. ;
Copie-Bergman, C. ;
Hemery, F. ;
Gaillard, I. ;
El Gnaoui, T. ;
Kuhnowski, F. ;
Bedoui, M. ;
Belhadj, K. ;
Brugieres, P. ;
Haioun, C. .
ANNALS OF ONCOLOGY, 2012, 23 (05) :1274-1279
[5]   LEPTOMENINGEAL TUMOR IN PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA - RECOGNITION, SIGNIFICANCE, AND IMPLICATIONS [J].
BALMACEDA, C ;
GAYNOR, JJ ;
SUN, M ;
GLUCK, JT ;
DEANGELIS, LM .
ANNALS OF NEUROLOGY, 1995, 38 (02) :202-209
[6]   Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system [J].
Baraniskin, Alexander ;
Kuhnhenn, Jan ;
Schlegel, Uwe ;
Chan, Andrew ;
Deckert, Martina ;
Gold, Ralf ;
Maghnouj, Abdelouahid ;
Zoellner, Hannah ;
Reinacher-Schick, Anke ;
Schmiegel, Wolff ;
Hahn, Stephan A. ;
Schroers, Roland .
BLOOD, 2011, 117 (11) :3140-3146
[7]   Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS dissemination [J].
Benevolo, Giulia ;
Stacchini, Alessandra ;
Spina, Michele ;
Ferreri, Andres J. M. ;
Arras, Marcella ;
Bellio, Laura ;
Botto, Barbara ;
Bulian, Pietro ;
Cantonetti, Maria ;
Depaoli, Lorella ;
Di Renzo, Nicola ;
Di Rocco, Alice ;
Evangelista, Andrea ;
Franceschetti, Silvia ;
Godio, Laura ;
Mannelli, Francesco ;
Pavone, Vincenzo ;
Pioltelli, Pietro ;
Vitolo, Umberto ;
Pogliani, Enrico M. .
BLOOD, 2012, 120 (16) :3222-3228
[8]   Natural History of CNS Relapse in Patients With Aggressive Non-Hodgkin's Lymphoma: A 20-Year Follow-Up Analysis of SWOG 8516-The Southwest Oncology Group [J].
Bernstein, Steven H. ;
Unger, Joseph M. ;
LeBlanc, Michael ;
Friedberg, Jonathan ;
Miller, Thomas P. ;
Fisher, Richard I. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (01) :114-119
[9]   CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL) [J].
Boehme, Volkmar ;
Schmitz, Norbert ;
Zeynalova, Samira ;
Loeffler, Markus ;
Pfreundschuh, Michael .
BLOOD, 2009, 113 (17) :3896-3902
[10]  
Buggage RR, 1999, INVEST OPHTH VIS SCI, V40, P2462